How to Get Finasteride in District of Columbia

What Finasteride Is and Why DC Residents Seek It

Finasteride is a type II and III 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen principally responsible for androgenetic alopecia (AGA) and prostatic growth. The FDA approved the 1 mg tablet (Propecia) for male-pattern hair loss in 1997 and the 5 mg tablet (Proscar) for BPH in 1992. 1

Both branded and generic versions are manufactured today. Generic finasteride 1 mg and 5 mg are widely stocked at DC-area pharmacies including CVS, Walgreens, and Giant Food Pharmacy, and at mail-order services such as Costco Pharmacy and Capsule.

In the Kaufman et al. two-year randomized controlled trial (N=1,553), 83% of men taking finasteride 1 mg daily maintained or increased hair count versus 28% in the placebo group. 2 Hair count increased by a mean of 277 hairs per square inch in the finasteride group at 24 months. Those numbers explain why demand for a prescription pathway in DC has grown steadily.

For BPH, the PLESS trial (N=3,040) showed finasteride 5 mg reduced prostate volume by 18% at one year and cut the risk of acute urinary retention by 57% over four years versus placebo. 3 DC urologists follow AUA guidelines that recommend finasteride for men with prostate volumes above 30 mL or serum PSA above 1.5 ng/mL. 4

DC Telehealth Law and Finasteride Prescribing

DC law explicitly permits synchronous and asynchronous telehealth encounters to establish a valid patient-physician relationship, which means a licensed DC provider may prescribe finasteride after a remote consultation. 5

Telehealth platforms operating in DC must verify that the prescribing clinician holds an active DC license issued by the DC Department of Health Board of Medicine, Board of Nursing, or Board of Pharmacy where applicable. A valid prescription for finasteride requires documentation of the indication (AGA or BPH), review of contraindications, and a discussion of potential adverse effects including sexual side effects reported in roughly 3.8% of men in key trials. 6

The encounter does not require a physical examination for AGA. Many platforms use a structured intake questionnaire plus optional photograph submission for hair-loss staging. For BPH, a clinician will typically want a recent PSA value before initiating 5 mg, because finasteride reduces PSA by approximately 50% within six months and a baseline is needed to interpret future values correctly. 7

After approval, the platform sends an e-prescription to any DC-licensed retail or mail-order pharmacy the patient chooses. Most platforms complete this within 24 hours of the intake submission.

In-Person Prescribing Options in DC

Patients who prefer a face-to-face visit can obtain finasteride through several specialist types in DC.

Dermatologists are the most common prescribers for AGA. The American Academy of Dermatology (AAD) guidelines list finasteride 1 mg daily as a first-line treatment for male-pattern hair loss, noting that "continuous use is required to maintain benefits." 8 DC has approximately 60 board-certified dermatologists, concentrated in the Dupont Circle, Georgetown, and Capitol Hill corridors.

Urologists handle most BPH prescriptions. Primary care physicians (internal medicine and family medicine) also prescribe finasteride for both indications and represent the most accessible entry point for uninsured or Medicaid patients.

Walk-in urgent care clinics generally do not prescribe finasteride because neither AGA nor BPH constitutes an acute complaint. Planned visits with a primary care provider or specialist remain the standard route for in-person access.

Who Can Legally Prescribe Finasteride in DC

DC licenses several prescriber categories, all of whom may legally write a finasteride prescription:

Physicians (MD and DO) holding a full DC medical license have unrestricted prescribing authority. Nurse Practitioners (NPs) in DC practice under full practice authority as of 2022, meaning they do not require physician supervision to prescribe. 9 Physician Assistants (PAs) prescribe under a supervision agreement with a DC-licensed physician but may independently manage finasteride prescriptions within that agreement.

All three practitioner types operate on DC-licensed telehealth platforms, so patients should not assume that an NP or PA encounter is clinically inferior to an MD visit for a well-characterized drug like finasteride.

What Labs Are Needed Before Starting Finasteride in DC

For AGA (1 mg), no mandatory laboratory workup exists in published guidelines. The AAD guidelines state that diagnosis of male-pattern hair loss is clinical, based on the Hamilton-Norwood classification. 10 Most telehealth platforms for AGA do not require labs before prescribing finasteride 1 mg.

For BPH (5 mg), the standard pre-treatment workup includes:

• Serum PSA (baseline required before finasteride alters the value)
• Urinalysis to exclude infection or hematuria
• Serum creatinine if renal obstruction is a concern
• Optional: post-void residual ultrasound

The AUA BPH guidelines recommend a baseline PSA in men aged 40 to 70 who are candidates for 5-alpha-reductase inhibitor therapy. 11 Patients who have had a PSA drawn within the previous 12 months can submit that result during a telehealth intake.

Some DC providers also check a baseline lipid panel or liver function tests at their discretion, though neither is required by FDA labeling or major guidelines. 12

HealthRX Pre-Treatment Checklist for Finasteride in DC

| Indication | Required Before Rx | Recommended But Optional | |---|---|---| | AGA (1 mg) | Clinical diagnosis (Hamilton-Norwood stage II+) | Baseline scalp photos, testosterone panel | | BPH (5 mg) | PSA within 12 months, urinalysis | Post-void residual, creatinine, IPSS score |

This framework standardizes what DC providers should collect before issuing a finasteride prescription, reducing prior-authorization delays when Medicaid is the payer.

How Long Until You Receive Finasteride in DC

Via telehealth, most patients receive an approved e-prescription within 24 hours of completing the intake form, assuming the provider finds no clinical reason to request additional information. Pharmacy processing at a DC retail location adds same-day to next-day turnaround. Mail-order delivery within DC zip codes typically takes one to three business days.

For in-person visits, scheduling wait times vary by specialty. Primary care appointments in DC average 19 days for new patients per the 2022 Merritt Hawkins survey data. 13 Dermatology appointments average 32 days in urban markets. Telehealth removes this bottleneck entirely.

Generic finasteride 1 mg is typically priced between $15 and $35 for a 30-day supply without insurance at DC pharmacies. GoodRx coupons can reduce that further. The 5 mg tablet, which some patients split for cost savings, may cost $10 to $20 per 30-count box.

DC Medicaid Coverage and Prior Authorization for Finasteride

DC Medicaid (administered through DC Healthy Families and Alliance programs) covers finasteride for both AGA and BPH, but prior authorization (PA) is required for both indications. 14

The PA process generally requires:

1. Documentation of the diagnosis (ICD-10 L64.9 for AGA, N40.1 for BPH with LUTS)
2. Evidence that the patient meets prescribing criteria (Hamilton-Norwood stage II or higher for AGA; prostate volume or symptom score threshold for BPH)
3. Prescriber attestation that the patient has been counseled on sexual side effects
4. For BPH: a recent PSA value and IPSS symptom score

Once submitted, DC Medicaid PA decisions for finasteride are typically returned within three to five business days for standard reviews or within 72 hours for expedited reviews when clinical urgency is documented. 15

The American Urological Association notes that "5-alpha-reductase inhibitors are appropriate for men with LUTS/BPH who have an enlarged prostate, as evidenced by prostate volume greater than 30 mL, PSA greater than 1.5 ng/mL, or prior diagnosis of prostatic enlargement." 4 Citing this language directly in the PA narrative can accelerate approval.

Most commercial insurance plans in DC cover generic finasteride with a Tier 1 or Tier 2 copay (typically $5 to $25 per month) without requiring PA, though coverage of the branded Propecia for AGA often does require PA or is excluded as a cosmetic benefit.

503A Compounding Pharmacies in DC

DC-licensed 503A pharmacies may compound finasteride for individual patients when a valid prescription exists and a commercially available product does not meet the patient's specific clinical need. Common compounding scenarios include:

• Topical finasteride formulations (e.g., 0.1% to 0.25% solution in ethanol or minoxidil base) for patients who experience systemic side effects from oral dosing
• Custom dose strengths for patients who require titration below 1 mg or above 1 mg but below 5 mg
• Combination formulas pairing finasteride with minoxidil in a single topical vehicle

The FDA regulates 503A pharmacies under section 503A of the Federal Food, Drug, and Cosmetic Act, requiring patient-specific prescriptions and prohibiting large-scale commercial distribution. 16

Topical finasteride has been studied in small trials. A 2018 pilot study published in JAMA Dermatology (N=41) found that topical finasteride 0.25% applied once daily achieved scalp DHT suppression comparable to oral finasteride 1 mg, with significantly lower serum DHT reduction, suggesting a potentially more localized mechanism of action. 17 DC providers may prescribe this off-label through a 503A pharmacy when patients report sexual side effects on the oral formulation.

Patients should confirm that the compounding pharmacy holds an active DC Board of Pharmacy license before filling a compounded prescription. The DC Board of Pharmacy maintains a public licensee search at doh.dc.gov.

Transferring an Existing Finasteride Prescription to DC

Patients relocating to DC from another state can transfer a finasteride prescription to any DC-licensed retail pharmacy. DC pharmacy law follows the standard model that a pharmacist may transfer a non-controlled prescription one time from an out-of-state pharmacy. 18

Finasteride is not a controlled substance under the DEA Schedules, so no additional transfer restrictions apply. The receiving DC pharmacist contacts the originating pharmacy to confirm the remaining refills and original prescription date.

If the original prescription has no remaining refills, the patient should contact the original prescribing provider for a new prescription or establish care with a DC-licensed provider, which telehealth makes achievable on the same day.

Mail-order pharmacies that hold multi-state dispensing licenses (Express Scripts, CVS Caremark, OptumRx) can continue shipping finasteride to a DC address without requiring a new prescription, provided refills remain on file and the prescribing provider holds an active license in their home state.

Side Effects, Contraindications, and Monitoring in DC Practice

Finasteride's most discussed adverse effects are sexual in nature. The key AGA trial showed erectile dysfunction in 1.3%, decreased libido in 1.8%, and ejaculation disorder in 1.2% of men on 1 mg versus 0.7%, 1.3%, and 0.8% on placebo, respectively. 19 These rates are low in absolute terms, though post-marketing reports of persistent sexual dysfunction after discontinuation (Post-Finasteride Syndrome) have been filed with the FDA MedWatch database and remain an active area of pharmacovigilance. 20

Finasteride is absolutely contraindicated in pregnancy. Women of childbearing potential should not handle crushed or broken tablets, because dermal absorption may cause ambiguous genitalia in a male fetus. 21 This warning is printed on the FDA-approved labeling and should be communicated by every DC provider at the point of prescribing.

For men on finasteride 5 mg, PSA should be rechecked six to twelve months after starting treatment to establish the new post-treatment baseline, then annually. A PSA that fails to decrease by approximately 50% from baseline, or that rises from the post-treatment nadir, warrants urology referral regardless of the absolute value. 22

Routine liver function testing is not required, because hepatic toxicity has not been established as a class effect at approved doses. 23

Combining Finasteride with Minoxidil in DC

Many DC providers prescribe finasteride alongside topical or oral minoxidil for AGA because the two drugs work through independent mechanisms, DHT suppression versus vasodilatory growth-phase prolongation. 24

A 2021 randomized controlled trial (N=90) published in the Journal of Cosmetic Dermatology found that finasteride 1 mg plus minoxidil 5% topical produced a 35.2% improvement in total hair count at 12 months, compared to 14.1% with finasteride alone. 25 The combination is not FDA-approved as a fixed-dose product but is widely used off-label.

Oral minoxidil at low doses (0.625 mg to 2.5 mg daily) has also gained traction in DC dermatology practices as an alternative to topical application. 26 DC telehealth providers can prescribe both drugs simultaneously during a single intake encounter.

Step-by-Step: Getting Your First Finasteride Prescription in DC

Step 1. Choose your access pathway: telehealth (same-day), primary care, or specialist. Telehealth is the fastest for AGA. BPH patients with no recent PSA should see a primary care provider or urologist first.

Step 2. Complete the intake. For telehealth AGA platforms, this means a questionnaire covering medical history, current medications, and sexual health baseline. Optional scalp photos help the provider stage the hair loss.

Step 3. The provider reviews and issues an e-prescription, typically within 24 hours. For BPH, submit any available PSA results at this stage.

Step 4. Choose a DC pharmacy. Retail options include CVS (multiple DC locations), Walgreens, and Rite Aid. Mail-order options include Capsule, Amazon Pharmacy, and major PBM mail services.

Step 5. Pick up or receive delivery. Generic finasteride 1 mg averages $15 to $35 per month without insurance. Use GoodRx or a manufacturer savings program if cost is a concern.

Step 6. Follow up at three months. Hair-loss response is assessed at six months; BPH symptom response is assessed at three to six months using the International Prostate Symptom Score (IPSS). 27